Neurolens: Funding, Investors & Team (Oct 2026)
Neurolens are prescription lenses that add a contoured prism to bring the eyes into alignment, relieving the headaches, neck or shoulder pain, and eyestrain that many people experience when using digital devices, reading, or doing detailed work. It was founded in 2012 and is headquartered in Costa Mesa, California.
Neurolens has raised $79.6M across 2 funding rounds on record, the most recent an undisclosed round of $67.6M announced in Sep 2022.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Neurolens Company Profile and Key Stats
Latest funding round on record: Sep 2022.
Neurolens Funding Rounds
Neurolens raised $12.0M in a Debt Financing announced in Nov 2021.
10 months later, an undisclosed round of $67.6M was announced in Sep 2022.
Neurolens Founders and Leadership Team
Contact details for the Neurolens team: 2 of 2 have an email address on file.
Start 14-day free trial →Neurolens Funding Compared to Other Biotechnology Startups
Neurolens' latest round of $67.6M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Neurolens in Biotechnology and Costa Mesa
Companies Similar to Neurolens
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Neurolens Funding FAQs
What does Neurolens do?
Neurolens are prescription lenses that add a contoured prism to bring the eyes into alignment, relieving the headaches, neck or shoulder pain, and eyestrain that many people experience when using digital devices, reading, or doing detailed work. It was founded in 2012 and is headquartered in Costa Mesa, California.
How much funding has Neurolens raised?
Neurolens has raised $79.6M across 2 rounds on record. The most recent is an undisclosed round of $67.6M announced in Sep 2022.
When did Neurolens last raise funding?
Neurolens' most recent funding round on record is an undisclosed round of $67.6M, announced in Sep 2022.
Who is the CEO of Neurolens?
Davis Corley is listed as CEO at Neurolens.
Where is Neurolens headquartered?
Neurolens is based in Costa Mesa, California, United States.
How many employees does Neurolens have?
Neurolens is in the 51-100 employee band.
How does Neurolens' funding compare to other Biotechnology startups?
Neurolens' latest round of $67.6M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Neurolens Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Neurolens is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.